140 related articles for article (PubMed ID: 9753210)
1. Coadministration of acetaminophen and troglitazone: pharmacokinetics and safety.
Young MA; Lettis S; Eastmond R
J Clin Pharmacol; 1998 Sep; 38(9):819-24. PubMed ID: 9753210
[TBL] [Abstract][Full Text] [Related]
2. Effects of acetaminophen, naproxen, and acetylsalicylic acid on tapentadol pharmacokinetics: results of two randomized, open-label, crossover, drug-drug interaction studies.
Smit JW; Oh C; Rengelshausen J; Terlinden R; Ravenstijn PG; Wang SS; Upmalis D; Mangold B
Pharmacotherapy; 2010 Jan; 30(1):25-34. PubMed ID: 20030470
[TBL] [Abstract][Full Text] [Related]
3. Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs.
Kawai K; Kawasaki-Tokui Y; Odaka T; Tsuruta F; Kazui M; Iwabuchi H; Nakamura T; Kinoshita T; Ikeda T; Yoshioka T; Komai T; Nakamura K
Arzneimittelforschung; 1997 Apr; 47(4):356-68. PubMed ID: 9150855
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of troglitazone, a PPAR-gamma agonist, in patients with hepatic insufficiency.
Ott P; Ranek L; Young MA
Eur J Clin Pharmacol; 1998 Sep; 54(7):567-71. PubMed ID: 9832300
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of troglitazone.
Loi CM; Young M; Randinitis E; Vassos A; Koup JR
Clin Pharmacokinet; 1999 Aug; 37(2):91-104. PubMed ID: 10496299
[TBL] [Abstract][Full Text] [Related]
6. Interactions between simvastatin and troglitazone or pioglitazone in healthy subjects.
Prueksaritanont T; Vega JM; Zhao J; Gagliano K; Kuznetsova O; Musser B; Amin RD; Liu L; Roadcap BA; Dilzer S; Lasseter KC; Rogers JD
J Clin Pharmacol; 2001 May; 41(5):573-81. PubMed ID: 11361054
[TBL] [Abstract][Full Text] [Related]
7. The effect of troglitazone biliary excretion on metabolite distribution and cholestasis in transporter-deficient rats.
Kostrubsky VE; Vore M; Kindt E; Burliegh J; Rogers K; Peter G; Altrogge D; Sinz MW
Drug Metab Dispos; 2001 Dec; 29(12):1561-6. PubMed ID: 11717175
[TBL] [Abstract][Full Text] [Related]
8. The role of conjugation in hepatotoxicity of troglitazone in human and porcine hepatocyte cultures.
Kostrubsky VE; Sinclair JF; Ramachandran V; Venkataramanan R; Wen YH; Kindt E; Galchev V; Rose K; Sinz M; Strom SC
Drug Metab Dispos; 2000 Oct; 28(10):1192-7. PubMed ID: 10997939
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone has no clinically significant effect on nifedipine pharmacokinetics.
Harris RZ; Inglis AM; Miller AK; Thompson KA; Finnerty D; Patterson S; Jorkasky DK; Freed MI
J Clin Pharmacol; 1999 Nov; 39(11):1189-94. PubMed ID: 10579151
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the human pharmacokinetics of troglitazone, a new and extensively metabolized antidiabetic agent, after oral administration, with an animal scale-up approach.
Izumi T; Enomoto S; Hosiyama K; Sasahara K; Shibukawa A; Nakagawa T; Sugiyama Y
J Pharmacol Exp Ther; 1996 Jun; 277(3):1630-41. PubMed ID: 8667232
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of an oral drug (acetaminophen) administered at various times in relation to subcutaneous injection of exenatide (exendin-4) in healthy subjects.
Blase E; Taylor K; Gao HY; Wintle M; Fineman M
J Clin Pharmacol; 2005 May; 45(5):570-7. PubMed ID: 15831781
[TBL] [Abstract][Full Text] [Related]
12. Improvement in the gastrointestinal absorption of troglitazone when taken with, or shortly after, food.
Young MA; Lettis S; Eastmond R
Br J Clin Pharmacol; 1998 Jan; 45(1):31-5. PubMed ID: 9489591
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone.
Spencer CM; Markham A
Drugs; 1997 Jul; 54(1):89-101; discussion 102. PubMed ID: 9211083
[TBL] [Abstract][Full Text] [Related]
14. Concomitant administration of cholestyramine influences the absorption of troglitazone.
Young MA; Lettis S; Eastmond R
Br J Clin Pharmacol; 1998 Jan; 45(1):37-40. PubMed ID: 9489592
[TBL] [Abstract][Full Text] [Related]
15. Effect of troglitazone on urinary excretion of 6beta-hydroxycortisol.
Koup JR; Anderson GD; Loi CM
J Clin Pharmacol; 1998 Sep; 38(9):815-8. PubMed ID: 9753209
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolites.
Loi CM; Alvey CW; Randinitis EJ; Abel R; Young MA; Koup JR
J Clin Pharmacol; 1997 Nov; 37(11):1038-47. PubMed ID: 9505997
[TBL] [Abstract][Full Text] [Related]
18. The comparative pharmacokinetics of modified-release and immediate-release paracetamol in a simulated overdose model.
Chiew A; Day P; Salonikas C; Naidoo D; Graudins A; Thomas R
Emerg Med Australas; 2010 Dec; 22(6):548-55. PubMed ID: 21143403
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect of type II diabetes on the pharmacokinetics of troglitazone in a multiple-dose study.
Loi CM; Randinitis EJ; Vassos AB; Kazierad DJ; Koup JR; Sedman AJ
J Clin Pharmacol; 1997 Dec; 37(12):1114-20. PubMed ID: 9506006
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of the insulin-sensitizing agent troglitazone in cats.
Michels GM; Boudinot FD; Ferguson DC; Hoenig M
Am J Vet Res; 2000 Jul; 61(7):775-8. PubMed ID: 10895899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
